Conclusions: An understanding of the indications for GLP-1 agonist use and associated adverse events can assist emergency clinicians.
Victoza (liraglutide) In 2017, the FDA approved Victoza (liraglutide) to reduce the risk of heart disease and stroke
Food and Drug Administration (FDA): Ozempic Prescribing Information National Institutes of Health (NIH): The Role of GLP-1 in Appetite Regulation and Central Satiety Signaling American Diabetes Association (ADA): Clinical Insights into Semaglutide and Glycemic Control Mechanisms Obesity Medicine Association (OMA): Understanding Homeostatic vs
No added sulphites, wheat, gluten, yeast, animal products, milk derivatives, eggs, soy bean products, lactose, sugars, artificial colours, flavours or preservatives
Remember, were here for you on this journey